Goodbody Health Limited (GDBYF)

Market Cap	36.00 -100.0%
Revenue (ttm)	18.35M +54.4%
Net Income	-4.15M
EPS	-0.11
Shares Out	36.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	205
Average Volume	21,543
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	n/a
Beta	67.64
RSI	44.73
Earnings Date	n/a

About Goodbody Health

Goodbody Health Limited provides various health checks and tests in the United Kingdom. The company offers women’s health tests, including menopause, female hormones, AMH fertility, pregnancy, and PCOS blood tests, as well as advanced well-woman tests; men’s health tests, such as male hormones, erectile dysfunction, and testosterone blood tests, as well as advanced well-man tests; prostate cancer tests; and prenatal blood tests comprising prenatal paternity, early baby gender blood, and various prenatalsafe NIPT blood tests. It also provides fo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Employees: 47
• Stock Exchange: OTCMKTS
• Ticker Symbol: GDBYF

Financial Performance

In 2021, Goodbody Health's revenue was 17.06 million, an increase of 755.37% compared to the previous year's 1.99 million. Losses were -2.31 million, -50.32% less than in 2020.

Financial numbers in GBP